Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Tyrosine-protein kinase JAK2 | ||
Ligand | BDBM325456 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | JAK2 Inhibition Assay | ||
IC50 | <10±n/a nM | ||
Citation | Allen, S; Boys, ML; Chicarelli, MJ; Fell, JB; Fischer, JP; Gaudino, J; Hicken, EJ; Hinklin, RJ; Kraser, CF; Laird, E; Robinson, JE; Tang, TP; Burgess, LE; Rieger, RA; Pheneger, J; Satoh, Y; Leftheris, K; Raheja, RK; Bennett, BL 4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors US Patent US10730880 Publication Date 8/4/2020 | ||
More Info.: | Get all data from this article, Assay Method | ||
Tyrosine-protein kinase JAK2 | |||
Name: | Tyrosine-protein kinase JAK2 | ||
Synonyms: | JAK-2 | JAK2 | JAK2_HUMAN | Janus kinase 2 | Janus kinase 2 (JAK2) | Janus kinase 2 (a protein tyrosine kinase) | ||
Type: | Protein | ||
Mol. Mass.: | 130684.68 | ||
Organism: | Homo sapiens (Human) | ||
Description: | O60674 | ||
Residue: | 1132 | ||
Sequence: |
| ||
BDBM325456 | |||
n/a | |||
Name | BDBM325456 | ||
Synonyms: | US10189845, Example 118 | US10730880, Example 121 | trans-4-(4-(4-(1-(pentan-3-yl)-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-6-yl)-1H-pyrazol-1-yl)cyclohexanol | ||
Type | Small organic molecule | ||
Emp. Form. | C23H29N7O | ||
Mol. Mass. | 419.5227 | ||
SMILES | CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(c1)C1CC[C@H](O)CC1 |r,wD:27.31,(.79,4.45,;-.3,3.36,;-1.78,3.76,;-2.18,5.25,;-1.09,6.34,;-2.87,2.67,;-2.4,1.21,;-3.64,.3,;-4.89,1.21,;-4.41,2.67,;-3.64,-1.24,;-2.31,-2.01,;-2.31,-3.55,;-3.64,-4.32,;-4.98,-3.55,;-6.44,-4.03,;-7.35,-2.78,;-6.44,-1.53,;-4.98,-2.01,;-.97,-4.32,;-.97,-5.86,;.49,-6.34,;1.4,-5.09,;.49,-3.84,;2.88,-4.69,;3.28,-3.2,;4.77,-2.81,;5.86,-3.89,;7.35,-3.5,;5.46,-5.38,;3.97,-5.78,)| | ||
Structure |